Ludwig Cancer Research
In research, Ludwig Cancer Research stands highest in Life Sciences (#419 of 14,347 worldwide), Immunology and Microbiology (#181 of 1,980 worldwide) and Medicine (#2,122 of 17,978 worldwide), over all time. Relative to its size it is most specialised in Immunology and Immunology and Microbiology — Immunology is 36.5× its share of world research.
- World rank, 2022–2025
- #2,045 of 28,054 · #1,266 all time
- Rank in Switzerland
- #23 of 220
- Research works
- 1.1k ▲ 24% vs 2013–17
- Citations
- 88k 82.7 per fractional work
- Top-10% rate
- 46.9% record average 16.5%
- Open access
- 51% world 28%
What is Ludwig Cancer Research known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #419 of 14,347 | 39.1% | 704 | |
| Immunology and MicrobiologyField | #181 of 1,980 | 37.1% | 426 | |
| MedicineField | #2,122 of 17,978 | 39.0% | 314 | |
| ImmunologySubfield | #167 of 1,394 | 37.3% | 420 | |
| Health SciencesDomain | #2,601 of 20,462 | 39.1% | 321 | |
| Biochemistry, Genetics and Molecular BiologyField | #1,626 of 7,814 | 42.2% | 258 | |
| Molecular BiologySubfield | #1,046 of 4,961 | 42.6% | 173 | |
| OncologySubfield | #516 of 1,852 | 38.3% | 129 |
Each strip is that field’s whole ranked pool, with the notch where Ludwig Cancer Research sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Ludwig Cancer Research specialise in?
Where its research is concentrated relative to its size: Immunology takes 36.5× the share of its output that it takes of world research.
- ImmunologySubfield · 24.5 works36×
- Immunology and MicrobiologyField · 25.1 works26×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 25.6×. Every wedge is a field page.
- Immunology and Microbiology 25.6×
- Biochemistry, Genetics and Molecular Biology 4.6×
- Medicine 2.1×
- Neuroscience 1.5×
- Nursing 0.9×
- Chemistry 0.4×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Engineering 0.2×
- Computer Science 0.1×
- Economics, Econometrics and Finance 0.1×
- Physics and Astronomy 0.1×
- Dentistry 0.1×
- Materials Science 0.1×
- Mathematics 0.1×
- Psychology 0.1×
- Decision Sciences 0.1×
- Social Sciences 0.0×
- Agricultural and Biological Sciences 0.0×
- Environmental Science 0.0×
Who are the top researchers at Ludwig Cancer Research?
Ranked on the composite score, G Miescher, Daniel E. Speiser and Jean‐Charles Cerottini lead among researchers whose main affiliation is Ludwig Cancer Research.
- 1 G Miescher Switzerland · #28,807 worldwide 229 citations · 86 works
- 2 Daniel E. Speiser Switzerland · #38,835 worldwide 571 citations · 55 works
- 3 Jean‐Charles Cerottini Switzerland · #51,066 worldwide 467 citations · 32 works
- 4 H. Robson MacDonald Switzerland · #76,709 worldwide 358 citations · 86 works
- 5 Pedro Romero Switzerland · #91,672 worldwide 463 citations · 73 works
- 6 Donata Rimoldi Switzerland · #137,882 worldwide 199 citations · 32 works
- 7 Philippe Guillaume Switzerland · #157,653 worldwide 149 citations · 45 works
- 8 S Carrel Switzerland · #222,163 worldwide 184 citations · 25 works
- 9 K. T. Brunner Switzerland · #318,192 worldwide 108 citations · 19 works
- 10 Danila Valmori Switzerland · #324,850 worldwide 136 citations · 26 works
Which keywords describe research at Ludwig Cancer Research?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunity, Immunotherapy, Tumor Microenvironment, Antigen Presentation, Innate Immunity, Cancer and Inflammation.
- Fc Receptors
- Cytokines
- Gene Therapy
- Foxp3
- TGF-ß
- Peptide-MHC Binding
- Epitope Prediction
- Chemotherapy
- Metastasis
- Activation
- Natural Killer Cells
- Metabolism
- Immune Checkpoint Blockade
- CAR T Cells
- Tumor Antigen
- Dendritic Cells
- Innate Immunity
- Antigen Presentation
- Tumor Microenvironment
- Immunity
- Cancer Immunotherapy
- Immunotherapy
- Inflammation
- Cancer
- Tumor Regression
- Lymphoma
- Vaccine Adjuvants
- Chimeric Antigen Receptor
- PD-1 and PD-L1
- NK Cell Recognition
- Macrophage
- Polarization
- Cancer Therapy
- Autoimmunity
- Glycosylation
- Biomarkers
- CD4+CD25+
- Gene Expression
- Angiogenesis
- Monoclonal Antibodies
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Immunotherapy15▲ 97×3 topics
- Immunity13▲ 33×8 topics
- Immunotherapy13▲ 18×13 topics
- Tumor Microenvironment11▲ 24×7 topics
- Inflammation10▲ 5.1×33 topics
- Antigen Presentation10▲ 118×2 topics
- Cancer9▲ 7.2×29 topics
- Innate Immunity9▲ 29×8 topics
- Tumor Regression8▲ 73×2 topics
- Dendritic Cells7▲ 83×2 topics
- Lymphoma7▲ 45×3 topics
- Tumor Antigen7▲ 117×1 topic
- Vaccine Adjuvants7▲ 117×1 topic
- CAR T Cells7▲ 96×1 topic
- Chimeric Antigen Receptor7▲ 96×1 topic
- Immune Checkpoint Blockade7▲ 63×1 topic
- PD-1 and PD-L17▲ 63×1 topic
- Metabolism6▲ 12×8 topics
- NK Cell Recognition6▲ 85×1 topic
- Natural Killer Cells6▲ 85×1 topic
- Macrophage5▲ 66×2 topics
- Activation4▲ 78×1 topic
- Polarization4▲ 30×1 topic
- Metastasis3▲ 10×9 topics
- Cancer Therapy3▲ 5.9×13 topics
- Chemotherapy3▲ 4.7×11 topics
- Autoimmunity3▲ 22×4 topics
- Epitope Prediction3▲ 120×1 topic
- Glycosylation3▲ 28×3 topics
- Peptide-MHC Binding3▲ 120×1 topic
- Biomarkers3▲ 4.5×7 topics
- TGF-ß3▲ 19×2 topics
- CD4+CD25+3▲ 86×1 topic
- Foxp33▲ 86×1 topic
- Gene Expression3▲ 4.8×9 topics
- Gene Therapy3▲ 14×4 topics
- Angiogenesis2▲ 7.6×7 topics
- Cytokines2▲ 7.9×5 topics
- Monoclonal Antibodies2▲ 24×2 topics
- Fc Receptors2▲ 38×1 topic
Which research topics does Ludwig Cancer Research publish most on?
By volume in 2022–2025: Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers and Immune Cell Function and Interaction.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immunotherapy and Immune Responses Immunology 7 works
- 2 CAR-T cell therapy research Oncology 7 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 7 works
- 4 Immune Cell Function and Interaction Immunology 6 works
- 5 Immune cells in cancer Immunology 4 works
- 6 vaccines and immunoinformatics approaches Molecular Biology 3 works
- 7 T-cell and B-cell Immunology Immunology 3 works
- 8 Cancer, Hypoxia, and Metabolism Cancer Research 2 works
- 9 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 10 Single-cell and spatial transcriptomics Molecular Biology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ludwig Cancer Research's research output changed?
Output in 2018–2022 was 24% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Zurich
- ETH Zurich
- University of Zurich
- University Hospital of Zurich
- Board of the Swiss Federal Institutes of Technology
- ABB (Switzerland)
- University Children's Hospital Zurich
- Zurich University of Applied Sciences in Business Administration
- Institute for Biomedical Engineering
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.